Literature DB >> 17656675

Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates.

Anjoeka Pronk1, Liesbeth Preller, Monika Raulf-Heimsoth, Irene C L Jonkers, Jan-Willem Lammers, Inge M Wouters, Gert Doekes, Adam V Wisnewski, Dick Heederik.   

Abstract

RATIONALE: Associations between oligomeric isocyanate exposure, sensitization, and respiratory disease have received little attention, despite the extensive use of isocyanate oligomers.
OBJECTIVES: To investigate exposure-response relationships of respiratory symptoms and sensitization in a large population occupationally exposed to isocyanate oligomers during spray painting.
METHODS: The prevalence of respiratory symptoms and sensitization was assessed in 581 workers in the spray-painting industry. Personal exposure was estimated by combining personal task-based inhalatory exposure measurements and time activity information. Specific IgE and IgG to hexamethylene diisocyanate (HDI) were assessed in serum by ImmunoCAP assay and enzyme immunoassays using vapor and liquid phase HDI-human serum albumin (HDI-HSA) and HSA conjugates prepared with oligomeric HDI.
MEASUREMENTS AND MAIN RESULTS: Respiratory symptoms were more prevalent in exposed workers than among comparison office workers. Log-linear exposure-response associations were found for asthmalike symptoms, chronic obstructive pulmonary disease-like symptoms, and work-related chest tightness (prevalence ratios for an interquartile range increase in exposure of 1.2, 1.3 and 2.0, respectively; P </= 0.05). The prevalence of specific IgE sensitization was low (up to 4.2% in spray painters). Nevertheless, IgE to N100 (oligomeric HDI)-HSA was associated with exposure and work-related chest tightness. The prevalence of specific IgG was higher (2-50.4%) and strongly associated with exposure.
CONCLUSIONS: The results provide evidence of exposure-response relationships for both work-related and non-work-related respiratory symptoms and specific sensitization in a population exposed to oligomers of HDI. Specific IgE was found in only a minority of symptomatic individuals. Specific IgG seems to be merely an indicator of exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656675      PMCID: PMC2176099          DOI: 10.1164/rccm.200702-215OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  Assessment of the relationship between isocyanate exposure levels and occupational asthma.

Authors:  S M Tarlo; G M Liss; C Dias; D E Banks
Journal:  Am J Ind Med       Date:  1997-11       Impact factor: 2.214

2.  Feasibility study of respiratory questionnaire and peak flow recordings in autobody shop workers exposed to isocyanate-containing spray paint: observations and limitations.

Authors:  M R Cullen; C A Redlich; W S Beckett; B Weltmann; J Sparer; G Jackson; T Ruff; E Rubinstein; W Holden
Journal:  Occup Med (Lond)       Date:  1996-06       Impact factor: 1.611

3.  Prevalence proportion ratios: estimation and hypothesis testing.

Authors:  T Skov; J Deddens; M R Petersen; L Endahl
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

4.  Evaluation of antibody binding to diisocyanate protein conjugates in a general population.

Authors:  David I Bernstein; M Gerald Ott; Michael Woolhiser; Zana Lummus; Cynthia Graham
Journal:  Ann Allergy Asthma Immunol       Date:  2006-09       Impact factor: 6.347

5.  An epidemiology study of lung function changes of toluene diisocyanate foam workers in the United Kingdom.

Authors:  R L Clark; J Bugler; M McDermott; I D Hill; D C Allport; J D Chamberlain
Journal:  Int Arch Occup Environ Health       Date:  1998-05       Impact factor: 3.015

Review 6.  Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Authors:  P J Sterk; L M Fabbri; P H Quanjer; D W Cockcroft; P M O'Byrne; S D Anderson; E F Juniper; J L Malo
Journal:  Eur Respir J Suppl       Date:  1993-03

Review 7.  Overview of diisocyanate occupational asthma.

Authors:  J A Bernstein
Journal:  Toxicology       Date:  1996-07-17       Impact factor: 4.221

8.  Asthma due to isocyanates: a mail survey in a 1% sample of furniture workers in the Veneto region, Italy.

Authors:  G Mastrangelo; P Paruzzolo; C Mapp
Journal:  Med Lav       Date:  1995 Nov-Dec       Impact factor: 1.275

9.  Hypersensitivity pneumonitis-like reaction and occupational asthma associated with 1,3-bis(isocyanatomethyl) cyclohexane pre-polymer.

Authors:  C Simpson; D Garabrant; S Torrey; T Robins; A Franzblau
Journal:  Am J Ind Med       Date:  1996-07       Impact factor: 2.214

Review 10.  Pathomechanisms and pathophysiology of isocyanate-induced diseases--summary of present knowledge.

Authors:  M Raulf-Heimsoth; X Baur
Journal:  Am J Ind Med       Date:  1998-08       Impact factor: 2.214

View more
  27 in total

1.  Airborne isocyanate exposures in the collision repair industry and a comparison to occupational exposure limits.

Authors:  Carolyn Reeb-Whitaker; Stephen G Whittaker; Diana M Ceballos; Elisa C Weiland; Sheila L Flack; Kenneth W Fent; Jennifer M Thomasen; Linda G Trelles Gaines; Leena A Nylander-French
Journal:  J Occup Environ Hyg       Date:  2012       Impact factor: 2.155

Review 2.  Risk factors, predictors, and markers for work-related asthma and rhinitis.

Authors:  Denyse Gautrin; Jean-Luc Malo
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

3.  Occupational exposure to HDI: progress and challenges in biomarker analysis.

Authors:  Sheila L Flack; Louise M Ball; Leena A Nylander-French
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-02-01       Impact factor: 3.205

4.  Inception cohort study of workers exposed to toluene diisocyanate at a polyurethane foam factory: initial one-year follow-up.

Authors:  Wei Gui; Adam V Wisnewski; Iulia Neamtiu; Eugen Gurzau; Judith A Sparer; Meredith H Stowe; Jian Liu; Martin D Slade; Olivia A Rusu; Carrie A Redlich
Journal:  Am J Ind Med       Date:  2014-09-29       Impact factor: 2.214

5.  Biomonitoring Hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-specific IgG.

Authors:  Adam V Wisnewski; Meredith H Stowe; Abby Nerlinger; Paul Opare-Addo; David Decamp; Christopher R Kleinsmith; Carrie A Redlich
Journal:  Ann Occup Hyg       Date:  2012-03-26

6.  Development of a source-exposure matrix for occupational exposure assessment of electromagnetic fields in the INTEROCC study.

Authors:  Javier Vila; Joseph D Bowman; Jordi Figuerola; David Moriña; Laurel Kincl; Lesley Richardson; Elisabeth Cardis
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-11-09       Impact factor: 5.563

Review 7.  Skin and respiratory chemical allergy: confluence and divergence in a hybrid adverse outcome pathway.

Authors:  Ian Kimber; Alan Poole; David A Basketter
Journal:  Toxicol Res (Camb)       Date:  2018-01-26       Impact factor: 3.524

8.  Reaction products of hexamethylene diisocyanate vapors with "self" molecules in the airways of rabbits exposed via tracheostomy.

Authors:  Adam V Wisnewski; Jean Kanyo; Jennifer Asher; James A Goodrich; Grace Barnett; Lyn Patrylak; Jian Liu; Carrie A Redlich; Ala F Nassar
Journal:  Xenobiotica       Date:  2017-06-01       Impact factor: 1.908

9.  Molecular Characterization and Experimental Utility of Monoclonal Antibodies with Specificity for Aliphatic Di- and Polyisocyanates.

Authors:  Adam V Wisnewski; Jian Liu
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2020-04-17

10.  Hemoglobin adducts in workers exposed to 1,6-hexamethylene diisocyanate.

Authors:  Sheila L Flack; Kenneth W Fent; Linda G T Gaines; Jennifer M Thomasen; Stephen G Whittaker; Louise M Ball; Leena A Nylander-French
Journal:  Biomarkers       Date:  2011-05       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.